Population kinetics of tobramycin in neonates

Therapeutic Drug Monitoring

Volumn 23, Issue 3, 2001, Pages 202-208

  Falcão, Amílcar Celta ^a   Buelga, Dolores Santos ^b   Méndez, Maria Eugenia ^c   García, Maria José ^b   Pardo, Marina ^c  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF SALAMANCA   (Spain)

^c HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

Author keywords

Neonatology; Population approach; Tobramycin

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; TOBRAMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; BIRTH WEIGHT; COMPARTMENT MODEL; DRUG CLEARANCE; DRUG METABOLISM; DRUG MONITORING; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN INFECTION; PRIORITY JOURNAL; STATISTICAL MODEL;

ANTI-BACTERIAL AGENTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFANT, NEWBORN; MALE; METABOLIC CLEARANCE RATE; MODELS, BIOLOGICAL; TOBRAMYCIN;

EID: 0035006231     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-200106000-00004     Document Type: Article

References (25)

1. Aarons L, Vozeh S, Wenk M, et al. Population pharmacokinetics of tobramycin. Br J Clin Pharmacol 1989;28:305-14.
2. Nahata MC, Powell DA, Durrell DE, Miller MA. Tobramycin pharmacokinetics in very low birth weight infants. Br J Clin Pharmacol 1986;21:325-7.
3. Carlstedt BC, Uaamnuichai M, Day RB, et al. Aminoglycoside dosing in pediatric patients. Ther Drug Monitor 1989;11:38-43.
4. Li RC, Zhu M, Schentag JJ. Achieving an optimal outcome in the treatment of infection: the role of clinical pharmacokinetics and pharmacodynamics of antimicrobials. Clin Pharmacokinet 1999; 37(1):1-16.
5. Burton ME, Brater C, Chen PS, et al. A Bayesian feedback method of aminoglycoside dosing. Clin Pharmacol Ther 1985;37:349-57.
6. De Hoog M, Schoemaker RC, Mounton JW, Anker JN. Tobramycin population pharmacokinetics in neonates. Clin Pharmacol Ther 1997;62:392-9.
7. Weber W, Kewitz G, Rost KL, et al. Population kinetics of gentamicin in neonates. Eur J Clin Pharmacol 1993;441(suppl 1): S23-5.
8. Brion LP, Fleischman AR, McCarton C, Schwartz GJ. A simple estimate of glomerular filtration rate in low birth weight infants during the first year of life: noninvasive assessment of body composition and growth. J Pediatr 1986;109:698-707.
9. Beal SL, Sheiner LB. NONMEM user's guides. San Francisco, CA: University of California-San Francisco; 1989.
10. Paisley JW, Smith AL, Smith DH, Follath F. Gentamicin in newborn infants: comparison of intramuscular and intravenous administration. Am J Dis Child 1973;126:473-7.
11. Sheiner LB, Rosenberg B, Marathe VV. Estimation of population characteristics of pharmacokinetic parameters from routine clinical data. J Pharmacokinet Biopharm 1977;5:445-79.
12. Vozeh S, Maitre, Stanski DR. Evaluation of population (NONMEM) pharmacokinetic parameter estimates. J Pharmacokinet Biopharm 1990;18:161-73.
13. Whiting B, Kelman AW, Grevel J. Population pharmacokinetics: theory and clinical application. Clin Pharmacol Ther 1986;26: 294-305.
14. Gilman JT, Gal P. Pharmacokinetic and pharmacodynamic data collection in children and neonates: a quiet frontier. Clin Pharmacokinet 1992;23:1-9.
15. Morselli PL, Franco-Morselli R, Bossi L. Clinical pharmacokinetics in newborns and infants: age-related differences and therapeutic implications. Clin Pharmacokinet 1980;5:485-527.
16. Fattinger K, Vozeh S, Olafsson A, et al. Netilmicin in the neonate: population pharmacokinetic analysis and dosing recommendations. Clin Pharmacol Ther 1991;50:55-65.
17. Izquierdo M, Lanal JM, Cervero L, et al. Population pharmacokinetics of gentamicin in premature infants. Ther Drug Monitor 1992;14:177-83.
18. Feldman H, Guignard JP. Plasma creatinine in the first month of life. Arch Dis Child 1982;57:123-6.
19. Paap CM, Nahata MC. Clinical pharmacokinetics of antibacterial drugs in neonates. Clin Pharmacokinet 1990;19:280-318.
20. Nahata MC, Glazer JP, Powell DA, et al. Pharmacokinetics of tobramycin in premature infants. Clin Pharmacol Ther 1983;33: 245.
21. Nahata MC, Powell DA, Barson WJ, et al. Tobramycin delivery and kinetics in newborn infants. Drug Intell Clin Pharm 1983;17: 439.
22. Nahata MC, Powell DA, Gregoire RP, et al. Tobramycin kinetics in newborn infants. J Pediatr 1983;103:136-8.
23. Ette El, Kelman AW, Howie CA, Whiting B. Interpretation of simulation studies for efficient estimation of population pharmacokinetic parameters. Ann Pharmacother 1993;27:1034-9.
24. Sun H, Fadiran EO, Jones CD, et al. Population pharmacokinetics: a regulatory perspective. Clin Pharmacokinet 1999;37:41-58.
25. Fernández de Gatta MM, García MJ, Lanao JM, Dominguez-Gil A. Bayesian forecasting in paediatric populations. Clin Pharmacokinet 1996;31:325-30.